Rowan E Miller (Rowan Miller)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Endometrial Cancer

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Therapeutic advances in medical oncology

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Eve Merry, Ronas Taner Kesmez, Tamara Yu, Michael Flynn, Jonathan A Ledermann, Michelle Lockley, Nicola Macdonald, Mary McCormack, Shibani Nicum, Shanthini Crusz, Rowan E Miller
A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Luke Steventon, Kenneth Keng Cheung Man, Shibani Nicum, Rowan E Miller, Shira Peleg Hasson, Samixa Shah, Michael Baser, Emma Kipps, Martin D Forster, Ofran Almossawi, Pinkie Chambers
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer. The oncologist (2024)
Michael-John Devlin, Rowan E Miller
Genomic testing in high-grade serous ovarian cancer: current options and future development. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Michael-John Devlin, Rowan E Miller
Genomic testing in high-grade serous ovarian cancer: current options and future development. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, Renaud Sabatier, Jubilee Brown, Sharad A Ghamande, Cara A Mathews, David M O'Malley, Rebecca S Kristeleit, Valentina Boni, Adriano Gravina, Susana Banerjee, Rowan E Miller, Joanna Pikiel, Mansoor Raza Mirza, Ninad Dewal, Grace Antony, Yuping Dong, Eleftherios Zografos, Jennifer T Veneris, Sarah A Cook
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
James F Spicer, Bristi Basu, Ana Montes, Udai Banerji, Rebecca S Kristeleit, Rowan E Miller, Gareth J Veal, Christopher J Corrigan, Stephen J Till, Alessandro Massimo Gianni, Silvana Canevari, Claire Barton, Paul Jones, Sarah Mellor, Simon Carroll, Chris Selkirk, George Nintos, Vineet Kwatra, Ionut-Gabriel Funingana, Gary J Doherty, Hannah J Gould, Giulia Pellizzari, Mano Nakamura, Kristina M Ilieva, Atousa Khiabany, Chara Stavraka, Jitesh Chauhan, Cheryl Gillett, Sarah E Pinder, Heather J Bax, Debra H Josephs, Sophia N Karagiannis
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. Nature communications 14 (1) (2023)
Helen Hockings, Rowan E Miller
The role of PARP inhibitor combination therapy in ovarian cancer. Therapeutic advances in medical oncology 15 (2023)
Michael-John Devlin, Rowan E Miller
Genomic testing in high-grade serous ovarian cancer: current options and future development. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Michael-John Devlin, Rowan E Miller, Florian Laforets, Panoraia Kotantaki, Dale W Garsed, Rebecca S Kristeleit, David D L Bowtell, Jacqueline McDermott, Eleni Maniati, Frances R Balkwill
The Tumor Microenvironment of Clear-Cell Ovarian Cancer. Cancer immunology research 10 (11) (2022)
Rowan E Miller, Karim Hussien El-Shakankery, Jung-Yun Lee
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies. Journal of gynecologic oncology 33 (3) (2022)
Shanthini M Crusz, Rowan E Miller
Targeted therapies in gynaecological cancers. Histopathology 76 (1) (2020)